{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:40:17Z","timestamp":1791999617071,"version":"4.4.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/wco.0b013e3282fee843","type":"journal-article","created":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T03:02:21Z","timestamp":1209610941000},"page":"331-337","source":"Crossref","is-referenced-by-count":26,"title":["Acute migraine therapy: recent evidence from randomized comparative trials"],"prefix":"10.1097","volume":"21","author":[{"given":"Anna","family":"Mett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Tfelt-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-18-20210206","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0895-4356(91)90147-2","article-title":"Epidemiology of headache in a general population\u2013a prevalence study","volume":"44","author":"Rasmussen","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"R5-18-20210206","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10194-005-0252-4","article-title":"The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF)","volume":"6","author":"Leonardi","year":"2005","journal-title":"J Headache Pain"},{"key":"R6-18-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10194-005-0169-y","article-title":"Intramuscular tramadol vs. diclofenac sodium for the treatment of acute migraine attacks in emergency department: a prospective, randomised, double-blind study","volume":"6","author":"Engindeniz","year":"2005","journal-title":"J Headache Pain"},{"key":"R9-18-20210206","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000047960","article-title":"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison","volume":"47","author":"Diener","year":"2002","journal-title":"Eur Neurol"},{"key":"R10-18-20210206","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1570161033386826","article-title":"Migraine: pathophysiology, pharmacology, treatment and future trends","volume":"1","author":"Villalon","year":"2003","journal-title":"Curr Vasc Pharmacol"},{"key":"R11-18-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: a review and European consensus","volume":"123","author":"Tfelt-Hansen","year":"2000","journal-title":"Brain"},{"key":"R12-18-20210206","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000047959","article-title":"Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study","volume":"47","author":"Geraud","year":"2002","journal-title":"Eur Neurol"},{"key":"R13-18-20210206","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-137-10-200211190-00014","article-title":"Pharmacologic management of acute attacks of migraine and prevention of migraine headache","volume":"137","author":"Snow","year":"2002","journal-title":"Ann Intern Med"},{"key":"R14-18-20210206","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1526-4610.2003.03161.x","article-title":"Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial","volume":"43","author":"Di Monda","year":"2003","journal-title":"Headache"},{"key":"R15-18-20210206","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"key":"R16-18-20210206","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200721110-00001","article-title":"Over-the-counter triptans for migraine: what are the implications?","volume":"21","author":"Tfelt-Hansen","year":"2007","journal-title":"CNS Drugs"},{"key":"R17-18-20210206","first-page":"39","article-title":"Standards of care for headache diagnosis and treatment. Treatment of primary headache: acute migraine treatment.","volume":"27-","author":"Landy","year":"2004","journal-title":"National Headache Foundation"},{"key":"R18-18-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.2006.00739.x","article-title":"Almotriptan and zolmitriptan in the acute treatment of migraine","volume":"115","author":"Goadsby","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"R19-18-20210206","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1474-7766.2004.03-205.x","article-title":"Acute migraine: which triptan?","volume":"4","author":"Gladstone","year":"2004","journal-title":"Pract Neurol"},{"key":"R20-18-20210206","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1212\/01.WNL.0000127304.91605.BA","article-title":"Use of narcotic analgesics in the emergency department treatment of migraine headache","volume":"62","author":"Colman","year":"2004","journal-title":"Neurology"},{"key":"R23-18-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(10)80017-4","article-title":"5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation","volume":"583","author":"Buzzi","year":"1992","journal-title":"Brain Res"},{"key":"R24-18-20210206","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1476-5381.1990.tb14679.x","article-title":"The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater","volume":"99","author":"Buzzi","year":"1990","journal-title":"Br J Pharmacol"},{"key":"R25-18-20210206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann Neurol"},{"key":"R26-18-20210206","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.297.13.1443","article-title":"Sumatriptan-naproxen for acute treatment of migraine: a randomized trial","volume":"297","author":"Brandes","year":"2007","journal-title":"JAMA"},{"key":"R27-18-20210206","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1526-4610.2005.05178.x","article-title":"Sumatriptan and naproxen sodium for the acute treatment of migraine","volume":"45","author":"Smith","year":"2005","journal-title":"Headache"},{"key":"R28-18-20210206","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/WNL.53.7.1468","article-title":"Increasing incidence of medically recognized migraine headache in a United States population","volume":"53","author":"Rozen","year":"1999","journal-title":"Neurology"},{"key":"R29-18-20210206","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","author":"Tfelt-Hansen","year":"2000","journal-title":"Cephalalgia"},{"key":"R30-18-20210206","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.58.11.1660","article-title":"Efficacy of oral ketoprofen in acute migraine: a double-blind randomized clinical trial","volume":"58","author":"Dib","year":"2002","journal-title":"Neurology"},{"key":"R31-18-20210206","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1468-2982.2004.00783.x","article-title":"Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks","volume":"24","author":"Diener","year":"2004","journal-title":"Cephalalgia"},{"key":"R32-18-20210206","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1468-2982.2002.00394.x","article-title":"Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Dowson","year":"2002","journal-title":"Cephalalgia"},{"key":"R33-18-20210206","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1742-1241.2007.01458.x","article-title":"Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study","volume":"61","author":"Sandrini","year":"2007","journal-title":"Int J Clin Pract"},{"key":"R34-18-20210206","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1526-4610.2006.00334.x","article-title":"Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial","volume":"46","author":"Saper","year":"2006","journal-title":"Headache"},{"key":"R35-18-20210206","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archneur.58.6.944","article-title":"Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison","volume":"58","author":"Spierings","year":"2001","journal-title":"Arch Neurol"},{"key":"R36-18-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/jnnp.64.2.143","article-title":"A triptan too far?","volume":"64","author":"Goadsby","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R37-18-20210206","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-1331.2006.01594.x","article-title":"Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy","volume":"14","author":"Lainez","year":"2007","journal-title":"Eur J Neurol"},{"key":"R38-18-20210206","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1468-1331.2006.01411.x","article-title":"EFNS guideline on the drug treatment of migraine - report of an EFNS task force","volume":"13","author":"Evers","year":"2006","journal-title":"Eur J Neurol"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e3282fee843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:04:54Z","timestamp":1786035894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-200806000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e3282fee843","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}